2019 Infusion Pharmacy Market Insight

There are a number of factors impacting the future of the infusion pharmacy market. New
reimbursement, drug shortages, PBMs, contracts and legislation are just a few of the obstacles an IV pharmacy
must navigate in order to grow. With so many challenges impeding success, which drivers contribute to a winning
strategy in 2019 and beyond?

A much deserved yet overdue thank you for your continued help and support of me with the questions that I ask of you from time to time. I appreciate your patience and perseverance in ensuring that you find the right answer for me.
Jeffrey E. Feldberg
Choosing someone that could mentor me with all of the nuances of this type of business was important. I was very fortunate to find Mark who has been instrumental in helping me understand not only what needed to be done but also how to accomplish it in the most effective, efficient way.
Tammy Miller
Being a pharmacist himself and owning his own businesses provides Ira with unique insight when working on behalf of a pharmacy owner… While working on my behalf, I observed several of Ira’s personality characteristics which helped create and keep the deal together; these being: people skills, positive attitude, decisiveness, creativity and intellect. In addition, during the transaction Ira was able to gain the respect of our prospective buyers with his expertise and style…
Ronald A. Memo, RPh
Ira Cammeyer is not a “business broker”. He and his colleagues are deal makers. They maximize your position in the market and represent you 110%. The association does not stop after the deal is done. Belonging to the “Ira” family brings you opportunities in the future. In addition, Ira is there for you. His opinion and network is just a phone call away.
Stanley R. Goldenberg, RPh, FASCP
Michael worked tirelessly in establishing financials that would convert our private business records into the format required for evaluation by potential capital partners. We could not be more pleased by the results and will continue our relationship with Harbor Healthcare so that they can assist us in finding potential acquisition targets.
Ron Belville, RPh